Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

By sjmartinez • July 24, 2024

Karpouzas GA, Ormseth SR, van Riel PLCM, Gonzalez-Gay MA, Corrales A, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Tsang L, Hitchon C, El-Gabalawy H, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, Misra DP, Hauge EM, Kitas G. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis. RMD Open. 2024 Jul 23;10(3):e004546. doi: 10.1136/rmdopen-2024-004546. PMID: 39043615.

Tags: Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Inflammation, Publications, Rheumatoid, Rheumatology

Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis

García-Sarreón A, Martinez-Lopez Y, Gómez-Figueroa E, Rivas-Alonso V, Flores J, Behne JM, Yeaman MR, Smith TJ, Behne MK, Delgado-Garcia G, Corona T. Patient-reported quality of[...]

Sex Differences in Aortic Arch Calcification With Zero Coronary Artery Calcium

Joshi MA, Manubolu VS, Kinninger A, Wang R, McClelland RL, Roy SK, Budoff MJ. Sex Differences in Aortic Arch Calcification With Zero Coronary Artery Calcium.[...]

Study protocol to evaluate an integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH: an open-label, usual care-controlled, randomized trial

Liu H, Shen J, Wang Y, Carnes TC, Hamilton AB, Witt MD, Daar ES. Study protocol to evaluate an integrated intervention using a pill ingestible[...]